VIrtual STudy in Achondroplasia for the US (VISTA)
← catalyst calendarNCT06168201 · readout ≤ 559 d
Sponsored by BioMarin Pharmaceutical (industry) · BMRN — their whole pipeline →. With PicnicHealth.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
170estimated
Sites
8
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-02-21 | actual | When the study began enrolling |
| Primary completion | Feb 2028 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Feb 2028 | estimated | The whole study's end, after follow-up |
| First posted | 2023-12-13 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-30 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Achondroplasia
Primary outcomes
what the primary-completion date above is the date OFHeight
measured Retrospective data and prospective data for up to 5 years starting from time of study enrolment
Weight
measured Retrospective data and prospective data for up to 5 years starting from time of study enrolment
Body Mass Index
measured Retrospective data and prospective data for up to 5 years starting from time of study enrolment
Head Circumference
measured Retrospective data and prospective data for up to 5 years starting from time of study enrolment
Annualized growth velocity (AGV)
measured Retrospective data and prospective data for up to 5 years starting from time of study enrolment
Medical diagnoses by age
measured Retrospective data and prospective data for up to 5 years starting from time of study enrolment
Surgical procedures and/or medical interventions by age
measured Retrospective data and prospective data for up to 5 years starting from time of study enrolment
Changes in physical functioning
measured every 6 months starting from time of study enrolment up to 5 years
Changes in health-related quality of life (HRQoL)
measured every 6 months starting from time of study enrolment up to 5 years
Adherence to treatment with VOXZOGO™ (vosoritide), if prescribed
measured every 6 months starting from time of study enrolment up to 5 years
Permalink · BMRN's whole pipeline · Catalyst calendar · Every registered study · What changed